Regeneris Medical
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease (NCT04352803) | Regeneris Medical | 2020-04-01 |
| Autologous Stem/Stromal Cells in Neurological Disorders and Disease (NCT03297177) | Regeneris Medical | 2020-01-01 |
Track Regeneris Medical automatically
Every clearance here is in the API, with alerts when new ones post.